These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7955198

  • 1. Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery.
    Ginsberg JS, Nurmohamed MT, Gent M, MacKinnon B, Sicurella J, Brill-Edwards P, Levine MN, Panju AA, Powers P, Stevens P.
    Circulation; 1994 Nov; 90(5):2385-9. PubMed ID: 7955198
    [Abstract] [Full Text] [Related]

  • 2. Direct thrombin inhibition with Rec-hirudin CGP 39393 as prophylaxis of thromboembolic complications after total hip replacement.
    Eriksson BI, Kälebo P, Ekman S, Lindbratt S, Kerry R, Close P.
    Thromb Haemost; 1994 Aug; 72(2):227-31. PubMed ID: 7831657
    [Abstract] [Full Text] [Related]

  • 3. Effects on thrombin generation of single injections of Hirulog in patients with calf vein thrombosis.
    Ginsberg JS, Nurmohamed MT, Gent M, MacKinnon B, Stevens P, Weitz J, Maraganore J, Hirsh J.
    Thromb Haemost; 1994 Oct; 72(4):523-5. PubMed ID: 7878625
    [Abstract] [Full Text] [Related]

  • 4. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
    Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F.
    Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
    [Abstract] [Full Text] [Related]

  • 5. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI, Ekman S, Lindbratt S, Baur M, Bach D, Torholm C, Kälebo P, Close P.
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [Abstract] [Full Text] [Related]

  • 6. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.
    Eriksson BI, Ekman S, Kalebo P, Zachrisson B, Bach D, Close P.
    Lancet; 1996 Mar 09; 347(9002):635-9. PubMed ID: 8596376
    [Abstract] [Full Text] [Related]

  • 7. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group.
    Hamulyák K, Lensing AW, van der Meer J, Smid WM, van Ooy A, Hoek JA.
    Thromb Haemost; 1995 Dec 09; 74(6):1428-31. PubMed ID: 8772214
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model.
    Hamelink JK, Tang DB, Barr CF, Jackson MR, Reid TJ, Gomez ER, Alving BM.
    J Vasc Surg; 1995 Mar 09; 21(3):492-8. PubMed ID: 7877232
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
    Spiro TE, Johnson GJ, Christie MJ, Lyons RM, MacFarlane DE, Blasier RB, Tremaine MD.
    Ann Intern Med; 1994 Jul 15; 121(2):81-9. PubMed ID: 8017740
    [Abstract] [Full Text] [Related]

  • 10. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery.
    Ginsberg JS, Brill-Edwards P, Panju A, Patel A, McGinnis J, Smith F, Dale I, Johnston M, Ofosu F.
    Thromb Haemost; 1995 Aug 15; 74(2):602-5. PubMed ID: 8584991
    [Abstract] [Full Text] [Related]

  • 11. Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosis.
    Reid T, Alving BM.
    Am J Hematol; 1994 Apr 15; 45(4):352-3. PubMed ID: 8192819
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    Eriksson BI, Wille-Jørgensen P, Kälebo P, Mouret P, Rosencher N, Bösch P, Baur M, Ekman S, Bach D, Lindbratt S, Close P.
    N Engl J Med; 1997 Nov 06; 337(19):1329-35. PubMed ID: 9358126
    [Abstract] [Full Text] [Related]

  • 13. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.
    Thromb Haemost; 1996 Feb 06; 75(2):246-50. PubMed ID: 8815569
    [Abstract] [Full Text] [Related]

  • 14. Hirulog: a direct thrombin inhibitor for management of acute coronary syndromes.
    Maraganore JM, Adelman BA.
    Coron Artery Dis; 1996 Jun 06; 7(6):438-48. PubMed ID: 8889359
    [Abstract] [Full Text] [Related]

  • 15. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.
    J Bone Joint Surg Am; 1994 Jan 06; 76(1):3-14. PubMed ID: 8288662
    [Abstract] [Full Text] [Related]

  • 16. Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial.
    Fuchs J, Cannon CP.
    Circulation; 1995 Aug 15; 92(4):727-33. PubMed ID: 7641350
    [Abstract] [Full Text] [Related]

  • 17. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
    White HD, Aylward PE, Frey MJ, Adgey AA, Nair R, Hillis WS, Shalev Y, Brown MA, French JK, Collins R, Maraganore J, Adelman B.
    Circulation; 1997 Oct 07; 96(7):2155-61. PubMed ID: 9337184
    [Abstract] [Full Text] [Related]

  • 18. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P, Pérez-Villa F, Waters D, Lespérance J, Shabani F, Bonan R.
    Circulation; 1995 Apr 15; 91(8):2132-9. PubMed ID: 7697841
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of postdischarge administration of enoxaparin in the prevention of deep venous thrombosis after total hip replacement. A prospective randomised double-blind placebo-controlled trial.
    Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Compan D, Saliba E, Weisslinger N, Huet Y.
    Drugs; 1996 Apr 15; 52 Suppl 7():47-54. PubMed ID: 9042560
    [Abstract] [Full Text] [Related]

  • 20. Hirudin: clinical potential of a thrombin inhibitor.
    Johnson PH.
    Annu Rev Med; 1994 Apr 15; 45():165-77. PubMed ID: 8198374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.